Trial intelligence / Profile preview

Impact of Tramadol vs Oxycodone on Sleep Apnea (TROXAT)

NCT03454217Phase 4Completed

Sponsor
Lausanne University Hospital
Start
Mar 2018
Primary completion
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial of tramadol in postoperative pain, sponsored by Lausanne University Hospital. Primary endpoint: Apnea hypopnea index while lying supine. Started Mar 2018; status: completed.

02

Drugs

tramadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03454217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03454217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call